Double-Edged Sword of Vitamin D3 Effects on Primary Neuronal Cultures in Hypoxic States.
Animals
Brain-Derived Neurotrophic Factor
/ metabolism
Calcium
/ metabolism
Cell Survival
/ drug effects
Cells, Cultured
Cholecalciferol
/ pharmacology
Hypoxia
/ drug therapy
Hypoxia-Inducible Factor 1, alpha Subunit
/ metabolism
Mice, Inbred C57BL
Neuroglia
/ drug effects
Neurons
/ drug effects
Neuroprotection
/ drug effects
Neuroprotective Agents
/ pharmacology
Receptor, trkB
/ metabolism
cholecalciferol
functional neural network activity
hypoxia
neuroprotection
primary neuronal cultures
vitamin D3
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 May 2021
21 May 2021
Historique:
received:
09
03
2021
revised:
03
05
2021
accepted:
17
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
23
6
2021
Statut:
epublish
Résumé
The use of vitamin D3 along with traditional therapy opens up new prospects for increasing the adaptive capacity of nerve cells to the effects of a wide range of stress factors, including hypoxia-ischemic processes. However, questions about prophylactic and therapeutic doses of vitamin D3 remain controversial. The purpose of our study was to analyze the effects of vitamin D3 at different concentrations on morpho-functional characteristics of neuron-glial networks in hypoxia modeling in vitro. We showed that a single administration of vitamin D3 at a high concentration (1 µM) in a normal state has no significant effect on the cell viability of primary neuronal cultures; however, it has a pronounced modulatory effect on the functional calcium activity of neuron-glial networks and causes destruction of the network response. Under hypoxia, the use of vitamin D3 (1 µM) leads to total cell death of primary neuronal cultures and complete negation of functional neural network activity. In contrast, application of lower concentrations of vitamin D3 (0.01 µM and 0.1 µM) caused a pronounced dose-dependent neuroprotective effect during the studied post-hypoxic period. While the use of vitamin D3 at a concentration of 0.1 µM maintained cell viability, preventive administration of 0.01 µM not only partially preserved the morphological integrity of primary neuronal cells but also maintained the functional structure and activity of neuron-glial networks in cultures. Possible molecular mechanisms of neuroprotective action of vitamin D3 can be associated with the increased expression level of transcription factor HIF-1α and maintaining the relationship between the levels of BDNF and TrkB expression in cells of primary neuronal cultures.
Identifiants
pubmed: 34063823
pii: ijms22115417
doi: 10.3390/ijms22115417
pmc: PMC8196622
pii:
doi:
Substances chimiques
Brain-Derived Neurotrophic Factor
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Neuroprotective Agents
0
Cholecalciferol
1C6V77QF41
Receptor, trkB
EC 2.7.10.1
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : We acknowledge the Lobachevsky University competitiveness program in the frame of 5-100 Russian Academic Excellence Project. The research was carried out using The Core Facilities «Molecular Biology and Neurophysiology» of Lobachevsky University.
Références
Nutr Neurosci. 2019 Sep 16;:1-10
pubmed: 31524100
J Neurosci. 2001 Jan 1;21(1):98-108
pubmed: 11150325
Metab Brain Dis. 2017 Apr;32(2):493-502
pubmed: 27975188
Nutrients. 2017 Jan 03;9(1):
pubmed: 28054941
Front Cell Neurosci. 2013 Sep 12;7:149
pubmed: 24062641
Med Sci Monit. 2020 Jul 26;26:e925350
pubmed: 32712621
Ann Nutr Metab. 2018;72(2):87-95
pubmed: 29346788
Dis Markers. 2019 May 2;2019:3652894
pubmed: 31191749
Antioxidants (Basel). 2020 Jul 24;9(8):
pubmed: 32722310
Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S
pubmed: 15585789
Mol Med Rep. 2013 Dec;8(6):1708-14
pubmed: 24141895
Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7069-7077
pubmed: 30402875
Food Chem Toxicol. 2019 Jan;123:142-150
pubmed: 30367913
Rev Endocr Metab Disord. 2017 Sep;18(3):335-346
pubmed: 28070798
Front Endocrinol (Lausanne). 2012 Apr 23;3:58
pubmed: 22649423
Oxid Med Cell Longev. 2015;2015:453901
pubmed: 26075035
J Autoimmun. 2019 Jun;100:7-16
pubmed: 30853311
Annu Rev Nutr. 2018 Aug 21;38:69-96
pubmed: 30130464
J Am Board Fam Med. 2009 Nov-Dec;22(6):698-706
pubmed: 19897699
Neuromolecular Med. 2018 Mar;20(1):147-159
pubmed: 29476479
EPMA J. 2017 Nov 15;8(4):313-325
pubmed: 29209434
Clin Interv Aging. 2018 Dec 10;13:2503-2509
pubmed: 30573955
Brain Res. 2007 Nov 14;1180:133-9
pubmed: 17920049
CNS Neurol Disord Drug Targets. 2019;18(6):478-490
pubmed: 31269889
Int J Cancer. 2016 Mar 1;138(5):1058-66
pubmed: 25784597
Nutrients. 2018 Jul 24;10(8):
pubmed: 30042334
Neurol Res. 2019 Sep;41(9):827-835
pubmed: 31142227
Nat Rev Mol Cell Biol. 2003 Jan;4(1):46-56
pubmed: 12511868
Int J Mol Med. 2018 Jan;41(1):364-372
pubmed: 29138801
Arch Biochem Biophys. 2021 Jan 15;697:108671
pubmed: 33181129
Curr Diab Rep. 2019 Sep 10;19(10):101
pubmed: 31506836
Curr Neuropharmacol. 2020;18(4):288-300
pubmed: 31701847
Neuropharmacology. 2017 Sep 1;123:186-200
pubmed: 28599922
Bone Res. 2016 Oct 18;4:16041
pubmed: 27790378
Brain Res. 2012 Aug 30;1471:46-55
pubmed: 22820296
Nutrients. 2017 Jun 24;9(7):
pubmed: 28672783
Noro Psikiyatr Ars. 2014 Jun;51(2):157-162
pubmed: 28360616
Neuropharmacology. 2001 May;40(6):761-71
pubmed: 11369030
Front Cell Dev Biol. 2018 Oct 10;6:132
pubmed: 30364203
Nutrients. 2019 Jul 26;11(8):
pubmed: 31357443
Trends Neurosci. 2019 Apr;42(4):293-306
pubmed: 30795846
Rev Endocr Metab Disord. 2017 Jun;18(2):153-165
pubmed: 28516265
Neurochem Res. 2019 Feb;44(2):347-356
pubmed: 30460641
Curr Vasc Pharmacol. 2017;15(2):115-122
pubmed: 27823556
Asia Pac Allergy. 2017 Apr;7(2):65-73
pubmed: 28487837
Exp Dermatol. 2011 Jan;20(1):7-13
pubmed: 21197695
BMC Med Genet. 2019 Apr 9;20(Suppl 1):49
pubmed: 30967121
Endocrinol Metab Clin North Am. 2017 Dec;46(4):1039-1059
pubmed: 29080634
Neonatology. 2018;113(4):305-312
pubmed: 29466806
Cell Mol Neurobiol. 2012 May;32(4):491-507
pubmed: 22297543
Brain Res. 2019 Dec 1;1724:146430
pubmed: 31479649
Pain Res Treat. 2015;2015:904967
pubmed: 26090221
Neurology. 2000 Jan 25;54(2):362-71
pubmed: 10668697
eNeurologicalSci. 2018 Dec 17;14:43-48
pubmed: 30619951
Eur J Endocrinol. 2012 May;166(5):765-78
pubmed: 22275473
Cerebrovasc Dis. 2015;40(1-2):73-80
pubmed: 26184826
J Matern Fetal Neonatal Med. 2016;29(14):2259-63
pubmed: 26372267